Overcast 70°
News
COVID-19: Results Of New Federal Study On Vaccine Effectiveness Released COVID-19: Results Of New Federal Study On Vaccine Effectiveness Released
Covid-19: Results Of New Federal Study On Vaccine Effectiveness Released A new study from the Centers for Disease Control and Prevention (CDC) has found that the COVID-19 vaccine has proven effective in preventing hospitalizations among older adults who are fully vaccinated. According to the CDC, the Pfizer and Moderna COVID vaccines are 94 percent effective in adults ages 65 and older who have received both doses of the shot and allowed 14 days to pass after the second dose. The study, which followed more than 400 hospitalized adults across 14 states from January to March, also found that the two-dose vaccines are 64 percent effective in the elderly who have o…

SHARE

by Zak Failla
Politics
COVID-19: CDC Announces Major New Guidance On Mask Wearing COVID-19: CDC Announces Major New Guidance On Mask Wearing
Covid-19: CDC Announces Major New Guidance On Mask Wearing The Centers for Disease Control & Prevention (CDC) has just released major new guidance on mask-wearing amid the COVID-19 pandemic. Under the new guidance, announced Tuesday afternoon, April 27, people who are fully vaccinated and who are outdoors no longer have to wear masks if they are gathered in small groups. Masks should still be worn at heavily attending outdoor gatherings, including concerts and sports events, where social distancing is not possible, the CDC said. It is also safe for those fully vaccinated to return to several activities inside, including attending religious ser…

SHARE

by Joe Lombardi
News
COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says COVID-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says
Covid-19: One Vaccine Dose May Be As Effective As Two For Those Who've Had Virus, Report Says New studies have found that Americans receiving the first dose of the two-shot Moderna and Pfizer COVID-19 vaccine may be protected against the spread of the vaccine. According to a Bloomberg report, out of more than 1,000 staff members tested at Cedars-Sinai Medical Center in Los Angeles, many responded to the first dose so robustly that their results were similar to co-workers who received both doses. Research leader Susan Cheng, who co-authored a study published in the Nature Medicine journal, said that those who have already contracted the virus, immune responses after one vaccine have …

SHARE

by Zak Failla
News
COVID-19: Here's How Many Have Missed Scheduled Second Dose Of Vaccine So Far, CDC Says COVID-19: Here's How Many Have Missed Scheduled Second Dose Of Vaccine So Far, CDC Says
Covid-19: Here's How Many Have Missed Scheduled Second Dose Of Vaccine So Far, CDC Says A larger number of Americans are skipping their scheduled second shot for the COVID-19 vaccine, according to new data released from the US Centers for Disease Control and Prevention. The CDC found that most recently, more than five million people, approximately 8 percent of those receiving vaccines from Moderna and Pfizer/BioNTech - which require two doses several weeks apart to complete the process - have skipped their second doses. That number is up from approximately 3.4 percent a month ago as the country was ramping up its vaccination program. Officials noted that the CDC is still coll…

SHARE

by Zak Failla
News
COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women COVID-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women
Covid-19: CDC Releases Results Of Study On Pfizer, Moderna Vaccine Use By Pregnant Women Results of the largest study conducted by the Centers for Disease Control and Prevention (CDC) on the use of two-dose COVID-19 vaccines by pregnant women have been released. The new study, published this week in the New England Journal of Medicine, found that out of more than 35,000 people who were pregnant or soon to become pregnant, there is no evidence to suggest that the Pfizer or Moderna COVID vaccines pose risk during pregnancy. Little data has been released on the Johnson & Johnson one-dose vaccine, which had run into production issues before distribution was paused following rep…

SHARE

by Zak Failla
News
COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says COVID-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says
Covid-19: Here's Number Of Americans Who've Become Infected Despite Being Vaccinated, CDC Says The Centers for Disease Control & Prevention (CDC) has released the first data on so-called "breakthrough" COVID-19 cases, meaning those who have become infected despite being fully vaccinated. So far, there have been about 5,800 such cases, the CDC told CNN.  At the time that data was collected, 77 million American adults had been fully vaccinated, meaning 99.992 percent had dodged the disease. The efficacy rates of the double-dose Pfizer and Moderna vaccines are both around 95 percent. "To date, no unexpected patterns have been identified in case demographics or vaccine ch…

SHARE

by Joe Lombardi
News
COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why COVID-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why
Covid-19: Side Effects Are More Likely After Second Pfizer Or Moderna Dose; Here's Why Feeling a bit sleepy, sore, and achy after getting your COVID-19 vaccine? Don't fret. Side effects are a sign that the body's immune system is responding to the dose, and that it's working, according to medical experts.  One of them, Dr.Allison Arwady, the Chicago Department of Public Health Commissioner, said younger people are more likely to experience side effects because they "have more robust immune system broadly," according to a report by NBC 5 Chicago. Women are also more likely to report side effects than men, Arwady said, noting estrogen can elevate immune response…

SHARE

by Joe Lombardi
News
COVID-19: Moderna Seeks Full FDA Approval For Vaccine COVID-19: Moderna Seeks Full FDA Approval For Vaccine
Covid-19: Moderna Seeks Full FDA Approval For Vaccine With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…

SHARE

by Zak Failla
News
COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines COVID-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines
Covid-19 Combo Pack: Mixup Leads To Man Getting One Dose Each Of Moderna, Pfizer Vaccines Call it a COVID-19 combo pack. A New England man is telling his story after a mixup led to him getting one dose each of the Moderna and Pfizer COVID-19 vaccines. New Hampshire resident Craig Richards quickly noticed on Tuesday, April 13 that the second dose he had just received was a Pfizer shot. His first dose had been the Moderna vaccine. "As soon as he poked me, he looked down at my card, and I think he realized he just gave me the Pfizer," Richards told ABC-TV affiliated WMUR of Manchester, New Hampshire. A supervisor at the site, the same place Richards received his first dose, …

SHARE

by Joe Lombardi
News
COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines COVID-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines
Covid-19: New Study Reveals How Prevalent Blood Clots Are With Pfizer, Moderna Vaccines The ratio of people who have suffered from blood clots after receiving the Moderna or Pfizer COVID-19 vaccine is approximately the same as those who receive the AstraZeneca vaccine, according to a new study. Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine. The new study comes in the wake of A…

SHARE

by Zak Failla
News
COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose COVID-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose
Covid-19: Pfizer CEO Reveals When Vaccine Booster Shot Likely Will Be Needed After Second Dose Pfizer CEO Albert Bourla is cautioning that patients will likely need a third dose of the company’s COVID-19 vaccine within the next year to maintain the shot’s efficacy. During a recently aired interview, Bourla said that patients will “likely” need an additional dose of the vaccine within 12 months of becoming fully vaccinated with the two required doses. Bourla said that they are continuing to monitor the situation, and as more COVID-19 variants arise, the company may be forced to shift gears. “We need to see what would be the sequence, and for how often we need to do that, that remains…

SHARE

by Zak Failla
News
COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses COVID-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses
Covid-19: Moderna Announces When Booster Shot Will Be Available For Those Who Got Two Doses Moderna is working on a booster shot for its two-dose COVID-19 vaccine that will be made available by the fall to help avoid another surge of new cases over the winter. CEO Stephane Bancel said on CNBC that the company “wants to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.” Last month, the National Institutes of Health began testing several versions of boosters from Moderna that could potentially be used to combat variants of COVID-19, including the South African strain that has flummoxed resear…

SHARE

by Zak Failla